tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Financial Statements

158 Followers

RenovoRx Financial Overview

RenovoRx's market cap is currently $42.30M. The company's EPS TTM is $-0.08; its P/E ratio is -2.66; RenovoRx is scheduled to report earnings on April 1, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.12M$ 43.00K$ 0.00$ 0.00$ 0.00
Gross Profit$ 796.00K$ 43.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -12.51M$ -10.97M$ -11.40M$ -9.95M$ -5.67M
EBITDA$ -12.51M$ -10.97M$ -11.39M$ -9.94M$ -5.48M
Net Income$ -11.17M$ -8.81M$ -10.23M$ -9.89M$ -6.32M
Balance Sheet
Cash & Short-Term Investments$ 7.02M$ 7.15M$ 1.17M$ 6.44M$ 15.19M
Total Assets$ 8.10M$ 8.12M$ 1.47M$ 7.26M$ 16.29M
Total Debt$ 107.00K$ 278.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -6.92M$ -6.88M$ -1.17M$ -4.39M$ -15.19M
Total Liabilities$ 2.67M$ 3.64M$ 4.47M$ 1.10M$ 938.00K
Stockholders' Equity$ 5.42M$ 4.48M$ -3.00M$ 6.16M$ 15.35M
Cash Flow
Free Cash Flow$ -10.97M$ -9.14M$ -10.26M$ -8.81M$ -5.93M
Operating Cash Flow$ -10.97M$ -9.13M$ -10.26M$ -8.81M$ -5.92M
Investing Cash Flow$ -2.00K$ -12.00K$ 2.03M$ -2.03M$ -15.00K
Financing Cash Flow$ 10.85M$ 15.12M$ 5.01M$ 42.00K$ 19.33M
Currency in USD

RenovoRx Earnings and Revenue History

RenovoRx Debt to Assets

RenovoRx Cash Flow

RenovoRx Forecast EPS vs Actual EPS